Longitude Capital logo

Longitude Capital

North America, California, United States, Menlo Park

Description

Longitude Capital is a venture capital firm that invests in biotechnology and medical technology companies.

Investor Profile

Longitude Capital has made 120 investments, with 12 in the past 12 months and 35% as lead.

Stage Focus

  • Series B (24%)
  • Series C (19%)
  • Series A (18%)
  • Series D (10%)
  • Series Unknown (9%)
  • Private Equity (5%)
  • Post Ipo Equity (5%)
  • Series E (3%)
  • Debt Financing (3%)
  • Series F (2%)

Country Focus

  • United States (90%)
  • Canada (4%)
  • Ireland (3%)
  • Switzerland (2%)
  • France (1%)
  • United Kingdom (1%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Medical Device
  • Biopharma
  • Health Diagnostics
  • Manufacturing
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Longitude Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 14
Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 7
Wellington Management
North America, Massachusetts, United States, Boston
Co-Investments: 7
Omega Funds
Europe, Geneve, Switzerland, Geneva
Co-Investments: 11
Kleiner Perkins
North America, California, United States, Menlo Park
Co-Investments: 8
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 7
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 20
Frazier Healthcare Partners
North America, Washington, United States, Seattle
Co-Investments: 11
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 8
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 7

Which angels does Longitude Capital often collaborate with?

AB
North America, Tennessee, United States, Nashville
Shared Deals: 1
EM
North America, California, United States, Redwood City
Shared Deals: 1

What are some of recent deals done by Longitude Capital?

MicroTransponder

Dallas, Texas, United States

MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases.

Health CareMedicalMedical Device
Series FMar 12, 2025
Amount Raised: $65,000,000
Helicore Biopharma

San Mateo, California, United States

Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.

BiopharmaBiotechnologyHealth CareMedicalTherapeutics
Series AJan 28, 2025
Amount Raised: $65,000,000
Aviceda Therapeutics

Cambridge, Massachusetts, United States

Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.

BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics
Series CJan 7, 2025
Amount Raised: $207,500,000
FIRE1

Dublin, Dublin, Ireland

FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series UnknownJan 7, 2025
Amount Raised: $120,000,000
VeraDermics

New Haven, Connecticut, United States

VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions such as warts.

Health CarePharmaceuticalTherapeutics
Series BDec 11, 2024
Amount Raised: $75,000,000
Alentis Therapeutics

Allschwil, Basel-Landschaft, Switzerland

ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.

BiotechnologyManufacturingPharmaceuticalTherapeutics
Series DNov 12, 2024
Amount Raised: $181,400,000
Alpha9 Theranostics

Vancouver, British Columbia, Canada

Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.

BiotechnologyMedicalProduct Research
Series COct 23, 2024
Amount Raised: $175,000,000
OrsoBio

Palo Alto, California, United States

OrsoBio is a clinical-stage biopharmaceutical company that develops therapies to treat severe metabolic disorders.

BiopharmaBiotechnologyHealth CareMedicalTherapeutics
Series BSep 6, 2024
Amount Raised: $67,000,000
Kestra Medical Technologies, Inc.

Kirkland, Washington, United States

Kestra Medical Technologies offers wearable medical devices which collects, store, and communicate patients vital performance data.

Health CareHealth DiagnosticsMedical Device
Private EquityJul 24, 2024
Amount Raised: $196,000,000
Endogenex

Plymouth, Minnesota, United States

Endogenex develops an endoscopic procedure to help patients with type 2 diabetes regain control of their blood glucose levels.

Health CareMedical DeviceTherapeutics
Series CJun 25, 2024
Amount Raised: $88,000,000